OBJECTIVE: To investigate the relationships among blood pressure (BP) values, antihypotensive therapies, and in-hospital outcomes to identify a BP threshold below which antihypotensive therapies may be beneficial. METHODS: Prospective observational study of infants 23(0/7) to 26(6/7) weeks' gestational age. Hourly BP values and antihypotensive therapy use in the first 24 hours were recorded. Low BP was investigated by using 15 definitions. Outcomes were examined by using regression analysis controlling for gestational age, the number of low BP values, and illness severity. RESULTS: Of 367 infants enrolled, 203 (55%) received at least 1 antihypotensive therapy. Treated infants were more likely to have low BP by any definition (P < .001), but for the 15 definitions of low BP investigated, therapy was not prescribed to 3% to 49% of infants with low BP and, paradoxically, was administered to 28% to 41% of infants without low BP. Treated infants were more likely than untreated infants to develop severe retinopathy of prematurity (15% vs 8%, P = .03) or severe intraventricular hemorrhage (22% vs 11%, P < .01) and less likely to survive (67% vs 78%, P = .02). However, with regression analysis, there were no significant differences between groups in survival or in-hospital morbidity rates. CONCLUSIONS: Factors other than BP contributed to the decision to use antihypotensive therapies. Infant outcomes were not improved with antihypotensive therapy for any of the 15 definitions of low BP investigated.
RCT Entities:
OBJECTIVE: To investigate the relationships among blood pressure (BP) values, antihypotensive therapies, and in-hospital outcomes to identify a BP threshold below which antihypotensive therapies may be beneficial. METHODS: Prospective observational study of infants 23(0/7) to 26(6/7) weeks' gestational age. Hourly BP values and antihypotensive therapy use in the first 24 hours were recorded. Low BP was investigated by using 15 definitions. Outcomes were examined by using regression analysis controlling for gestational age, the number of low BP values, and illness severity. RESULTS: Of 367 infants enrolled, 203 (55%) received at least 1 antihypotensive therapy. Treated infants were more likely to have low BP by any definition (P < .001), but for the 15 definitions of low BP investigated, therapy was not prescribed to 3% to 49% of infants with low BP and, paradoxically, was administered to 28% to 41% of infants without low BP. Treated infants were more likely than untreated infants to develop severe retinopathy of prematurity (15% vs 8%, P = .03) or severe intraventricular hemorrhage (22% vs 11%, P < .01) and less likely to survive (67% vs 78%, P = .02). However, with regression analysis, there were no significant differences between groups in survival or in-hospital morbidity rates. CONCLUSIONS: Factors other than BP contributed to the decision to use antihypotensive therapies. Infant outcomes were not improved with antihypotensive therapy for any of the 15 definitions of low BP investigated.
Authors: Andrew K Ewer; Wendy Tyler; Andre Francis; Donna Drinkall; Jason O Gardosi Journal: Paediatr Perinat Epidemiol Date: 2003-04 Impact factor: 3.980
Authors: S E Martens; M Rijken; G M S J Stoelhorst; P H T van Zwieten; A H Zwinderman; J M Wit; M Hadders-Algra; S Veen Journal: Early Hum Dev Date: 2003-12 Impact factor: 2.079
Authors: Erika Fernandez; Kristi L Watterberg; Roger G Faix; Bradley A Yoder; Michele C Walsh; Conra Backstrom Lacy; Karen A Osborne; Abhik Das; Douglas E Kendrick; Barbara J Stoll; Brenda B Poindexter; Abbot R Laptook; Kathleen A Kennedy; Kurt Schibler; Edward F Bell; Krisa P Van Meurs; Ivan D Frantz; Ronald N Goldberg; Seetha Shankaran; Waldemar A Carlo; Richard A Ehrenkranz; Pablo J Sánchez; Rosemary D Higgins Journal: Am J Perinatol Date: 2015-03-31 Impact factor: 1.862
Authors: Beau Batton; Lei Li; Nancy S Newman; Abhik Das; Kristi L Watterberg; Bradley A Yoder; Roger G Faix; Matthew M Laughon; Barbara J Stoll; Rosemary D Higgins; Michele C Walsh Journal: Arch Dis Child Fetal Neonatal Ed Date: 2015-11-13 Impact factor: 5.747
Authors: Christopher J Rhee; Charles D Fraser; Kathleen Kibler; Ronald B Easley; Dean B Andropoulos; Marek Czosnyka; Georgios V Varsos; Peter Smielewski; Craig G Rusin; Ken M Brady; Jeffrey R Kaiser Journal: Pediatr Res Date: 2015-03-31 Impact factor: 3.756
Authors: Barbara J Stoll; Karen M Puopolo; Nellie I Hansen; Pablo J Sánchez; Edward F Bell; Waldemar A Carlo; C Michael Cotten; Carl T D'Angio; S Nadya J Kazzi; Brenda B Poindexter; Krisa P Van Meurs; Ellen C Hale; Monica V Collins; Abhik Das; Carol J Baker; Myra H Wyckoff; Bradley A Yoder; Kristi L Watterberg; Michele C Walsh; Uday Devaskar; Abbot R Laptook; Gregory M Sokol; Stephanie J Schrag; Rosemary D Higgins Journal: JAMA Pediatr Date: 2020-07-06 Impact factor: 16.193